Brought to you by the Advanced Medical Technology Association (AdvaMed), MedTech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective. Tune in to each episode for interesting discussions with medtech and health care policy leaders on issues that are driving the day—from business, to policy, and current events, all viewed through the lens of the medtech industry.
AdvaMed President and CEO Scott Whitaker sits down with just-retired U.S. Rep. Brad Wenstrup of Ohio, discussing lessons learned from the COVID-19 pandemic, illogical budgetary scoring of health care procedures, and Wenstrup's life-saving triage of U.S. House of Representatives Majority Leader Steve Scalise after a shooting. AdvaMed, the Medtech Association, is the world's largest trade association for the medical technology industry, representing more than 500 companies around the world that are developing life-changing and life-saving medical technologies for patients. To learn more about AdvaMed, the Medtech Association, visit www.advamed.org.
AdvaMed President and CEO Scott Whitaker sits down with Jacob “Jake” Leach, Executive Vice President and Chief Operating Officer at Dexcom, to discuss the latest innovations from the company that provide millions of people easy ways to monitor their glucose levels. AdvaMed, the Medtech Association, is the world's largest trade association for the medical technology industry, representing more than 500 companies around the world that are developing life-changing and life-saving medical technologies for patients. To learn more about AdvaMed, the Medtech Association, visit www.advamed.org.
AdvaMed President and CEO Scott Whitaker sits down with professional tennis legends Martina Navratilova and Chris Evert, who met as teen-age competitors and whose friendship of 50-plus years has deepened over each surviving cancer. AdvaMed, the Medtech Association, is the world's largest trade association for the medical technology industry, representing more than 500 companies around the world that are developing life-changing and life-saving medical technologies for patients. To learn more about AdvaMed, the Medtech Association, visit www.advamed.org.
In the first episode of the new Medtech POV series on AI in health care, AdvaMed President and CEO Scott Whitaker sits down with Troy Tazbaz, Director of the Digital Health Center of Excellence within FDA's Center for Devices and Radiological Health. The two discuss the rapid innovation in health care and the path forward as we see more AI/ML-enabled medical technologies in the doctor's office. AdvaMed, the Medtech Association, is the world's largest trade association for the medical technology industry, representing nearly 500 companies around the world that are developing life-changing and life-saving medical technologies for patients. To learn more about AdvaMed, the Medtech Association, visit www.advamed.org.
AdvaMed President and CEO Scott Whitaker sits down with Steve Mapa, Executive Director of MedTechVets, to talk about the organization's commitment to supporting military veterans as they begin careers in the medtech industry. AdvaMed, the Medtech Association, is the world's largest trade association for the medical technology industry, representing nearly 500 companies around the world that are developing life-changing and life-saving medical technologies for patients. To learn more about AdvaMed, the Medtech Association, visit www.advamed.org. To learn more about MedTechVets, visit: www.medtechvets.org.
AdvaMed President and CEO Scott Whitaker sits down with Nancy Brown, President of the American Heart Association to talk about AHA's 100th anniversary and the role medical technology has played in reducing cardiovascular disease deaths. AdvaMed, the Medtech Association, is the world's largest trade association for the medical technology industry, representing nearly 500 companies around the world that are developing life-changing and life-saving medical technologies for patients. To learn more about AdvaMed, the Medtech Association, visit www.advamed.org. To learn more about the American Heart Association, visit www.heart.org.
AdvaMed President and CEO Scott Whitaker sits down for a conversation with Venk Varadan, co-founder and CEO of Nanowear. The two talk about Venk's journey as a medtech entrepreneur, the applications of nanotechnology and artificial intelligence (AI) in health care, and the process his startup went through to go from research and development to FDA approval. AdvaMed, the Medtech Association, is the world's largest trade association for the medical technology industry, representing nearly 500 companies around the world that are developing life-changing and life-saving medical technologies for patients. To learn more about AdvaMed, the Medtech Association, visit www.advamed.org. Learn more about Nanowear: www.nanowearinc.com
In this episode of the Medtech POV Podcast, host Scott Whitaker talks with Dr. Lishan Aklog, CEO of PAVmed and Lucid Diagnostics. Dr. Aklog, a heart surgeon and medtech entrepreneur, shares his perspective on the latest advancements in medical technology, the future of health care innovation, and how we can get breakthrough technology into the hands of patients. Tune in to gain valuable knowledge from one of the industry's leading voices. Don't miss out on this insightful journey into the world of medtech! Subscribe to the Medtech POV Podcast today. Learn more about AdvaMed: www.advamed.org
Former United States Senator Richard Burr served North Carolina for nearly 3 decades both houses of Congress, and in that time he became a well-regarded expert in health policy. And as chair of the Senate Intelligence committee, he also became a widely respected expert in national security. Senator Burr joined me to talk about the intersection of Congressional politics and health care, the state of our current political climate, and the role of AI in the future of health care delivery.
Caroll Neubauer has a distinguished career in medtech, as the former long-time leader of B. Braun Medical Inc., now an adviser at Water Street Healthcare Partners, and co-chairman of The MedTech Conference Steering Committee. Caroll joined me on the Medtech POV podcast and previewed The MedTech Conference, Oct. 9-11, in Anaheim, California.
Dr. Peter Schneider, Professor of Surgery in the Division of Vascular & Endovascular Surgery at the University of California San Francisco, and Dr. Justin Klein, AdvaMed board member and co-founder at Vensana Capital joined AdvaMed's Scott Whitaker to talk about a recent New York Times story about atherectomies and peripheral artery disease (PAD) and the impact the story could have on patients seeking treatment for this condition.
AdvaMed President and CEO Scott Whitaker sits down for a wide-ranging discussion with Michael Minogue, former Chairman, President, and CEO of Abiomed. The lively conversation, encompassing Minogue's military career to his decades of work in the medtech industry, highlights his entrepreneurial work ethic, leadership values, the lifesaving innovation the medtech industry is responsible for, and the ongoing work to help transitioning servicemembers find meaningful careers in the health care industry.
AdvaMed's Scott Whitaker sits down on the latest episode of the MedTech POV podcast with Dr. Lucy Frasier to discuss the recent news about ethylene oxide (EtO), the real risks caused by the naturally occurring chemical, and what would happen to health care delivery if the chemical was banned as a sterilizer of medical devices and component parts.
Cary Vance, President and CEO of Titan Medical, joins AdvaMed's Scott Whitaker to share his experience leading a small medical device company through the regulatory process as they transition from design to manufacturing.
Mick Farrell, ResMed CEO and member of the AdvaMed board of directors, joined AdvaMed's Scott Whitaker on the MedTech POV podcast to discuss how an agile company with skilled staff and a clear mission can pivot sharply as the market demands, from scaling up ventilator production at the outset of the COVID-19 pandemic to informing semiconductor chips manufacturers of their product's critical importance to the medical technology industry.
Derek Herrera, former Marine and current Board President of MedTechVets, Founder and CEO of Bright Uro, joined AdvaMed's Scott Whitaker on the MedTech POV podcast to talk about his experiences, from his paralysis by a sniper's bullet in Afghanistan to his subsequent career as a medtech entrepreneur, and what he sees for the future of the industry. Watch a heartwarming video of Derek standing up from his wheelchair for the first time in front of his two young sons using exoskeletal medical technology. https://www.youtube.com/watch?v=pCTBn2SSUjg
Mike Mussallem, Chairman and CEO of Edwards Lifesciences joined AdvaMed's Scott Whitaker on the Medtech POV podcast to talk about changes to federal policy that could speed up the process of getting life-saving medical technology to patients.
Lishan Aklog, MD, Chairman and CEO of PAVmed joined AdvaMed's Scott Whitaker on the Medtech POV podcast to talk about the way the reimbursement system works for medtech companies and the impact it has on raising capital and getting life-saving medical technology to patients.
Lisa Earnhardt, Executive Vice President, Medical Devices, at Abbott joined AdvaMed's Scott Whitaker on the Medtech POV podcast to discuss how innovation and technology are helping patients manage diabetes, allowing them to live fuller and better lives.
Nadim Yared, President and CEO of medical technology startup CVRx recently joined AdvaMed's Scott Whitaker on the Medtech POV Podcast to discuss his expansive career in medtech – from engineer to CEO – and how his work to improve communication between the Food & Drug Administration and the medtech industry has vastly changed over the years.
Nadim Yared, President and CEO of medical technology startup CVRx recently joined AdvaMed's Scott Whitaker on the Medtech POV Podcast to discuss his expansive career in medtech – from engineer to CEO – and how his work to improve communication between the Food & Drug Administration and the medtech industry has vastly changed over the years.
Justin Klein, cofounder and Managing Partner at Vensana Capital, a top venture capital and growth investment firm focused on funding innovation in the medical technology world, discusses the Medicare Coverage of Innovative Technologies (MCIT) rule and the role venture capital firms like his play overall in the process of bringing promising new medical technologies to market.
Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices, at Johnson & Johnson recently joined AdvaMed's Scott Whitaker to discuss her views on leadership, her work with the Trevor Project, and her role as chair of the AdvaMed committee tasked with addressing head-on the issue of racial disparities in health care access and outcomes.
BD Chairman, Chief Executive Officer, and President Tom Polen recently joined AdvaMed's Scott Whitaker on the Medtech POV podcast to talk about how BD developed and launched COVID-19 diagnostic tests in an unprecedented 90 days. Polen opens up about his role at the leading medical technology company, and how his team of more than 70,000 associates took a three-year development process and condensed it to three months to help people around the globe.
Hologic President and CEO Steve MacMillan leads host Scott Whitaker, president and CEO of AdvaMed, through a retrospective on the company's more than tripling of total molecular diagnostic manufacturing capacity in order to meet the demands of the COVID-19 pandemic and help save lives.
President and CEO of AdvaMed Scott Whitaker sits down with one of the industry's top recruiters and head of The Mullings Group, Joe Mullings. Whitaker and Mullings discuss what makes a great leader, how those seeking to work in medtech can navigate the field's changing dynamics, and how we as an industry and nation can expand access to health care, among other top issues.
Olympus is one of the most important and innovative players in the medical technology industry. At the helm is Nacho Abia, who joins MedTech POV host and AdvaMed CEO Scott Whittaker in this episode to discuss some of the most exciting advances in medtech today. Tune in to hear Abia talk about his role as a leader at Olympus, including a focus on patient-centered care and diversity, equity and inclusion initiatives. Learn more about Olympus: https://www.olympus-global.com/
A critical department at the FDA, the Center for Devices and Radiological Health (CDRH) is responsible for protecting and promoting the public health through medical device innovation. Dr. Jeffrey Shuren, one of the longest-serving directors of the CDRH, sat down with MedTech POV to share his insight on how medtech and government can work together to solve today's toughest health challenges.
President and CEO of AdvaMed Scott Whitaker catches up with Dr. Steve Hahn. Before Hahn was the head of FDA, he worked as a medical oncologist, served as a commander in the U.S. Public Health Service Commissioned Corps, managed research for the NIH, and was appointed as the Chief Medical Executive of MD Anderson Cancer Center — all before he was nominated, confirmed, and sworn in as the Commissioner of the Food and Drug Administration in late 2019. Whitaker and Hahn cover many topics, including Dr. Hahn's time as head of FDA during the worst pandemic in a century.
Welcome to the first episode of MedTech POV, a podcast brought to you by AdvaMed, the leading trade organization for medical technology companies, and hosted by CEO, Scott Whitaker. Here at the MedTech POV podast, we'll give you an up-close look at what's going on in the medical technology community. Tune in to each episode for conversations with today's leaders – both inside and outside our industry – about business, policy, and current events. In this episode, we have with us General James Mattis – a 4-star Marine General who spent more than 40 years commanding forces in the Persian Gulf War, the War in Afghanistan, the Iraq War and, of course, as a former Secretary of Defense. He's a true leader, he's one of the best strategic thinkers of our time, and, perhaps above all, he's a servant of our country in every sense of the word. General Mattis spoke to our board a few weeks ago, and it was such a great discussion, we decided to share a portion of the discussion and Q&A with you all here. Listen in a we pick his brain about everything from Covid-19 and international trade relations to how he got his famous call sign, Chaos. And what book does General Mattis think every medtech leader should read? You've gotta listen to find out.